Hudson Bay Capital Management »

Nls Pharmaceutics shares owned by Hudson Bay Capital Management

Quarter-by-quarter ownership of Nls Pharmaceutics (NLSPW) shares owned by Hudson Bay Capital Management from 13F filings

Historical chart of Hudson Bay Capital Management investment in Nls Pharmaceutics

Tip: Access up to 7 years of quarterly data

All positions including Nls Pharmaceutics held by Hudson Bay Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nls Pharmaceutics by Hudson Bay Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $3.0k 100k 0.03
2024-03-31 $4.9k 100k 0.05
2023-12-31 $5.6k 100k 0.06
2023-09-30 $11k 100k 0.11
2023-06-30 $10k 100k 0.10
2023-03-31 $15k 100k 0.15
2022-12-31 $28k 100k 0.28
2022-06-30 $12k 100k 0.12
2022-03-31 $38k 100k 0.38
2021-12-31 $165k 200k 0.83
2021-09-30 $154k 200k 0.77
2021-06-30 $192k 200k 0.96
2021-03-31 $190k 200k 0.95

More positions owned by Hudson Bay Capital Management

NVIDIA Corporation Call Option (NVDA)
Amazon Call Option (AMZN)
Microsoft Corporation Call Option (MSFT)
Apple Call Option (AAPL)
Eli Lilly & Co. Put Option (LLY)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Dollar Tree Put Option (DLTR)
Brookfield Corp Cl A Ltd Vt Sh Put Option (BN)
Taiwan Semiconductor Mfg Sponsored Ads Put Option (TSM)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Advanced Micro Devices Put Option (AMD)
Royal Caribbean Group Note 6.000% 8/1 (Principal)
Meta Platforms Cl A Put Option (META)
Broadcom Put Option (AVGO)
Boeing Company Put Option (BA)

View all positions for Hudson Bay Capital Management

Top funds holding Nls Pharmaceutics

Armistice Capital
Altium Capital Management
Hudson Bay Capital Management
Citadel Advisors
Susquehanna International
Clear Street

View all funds holding Nls Pharmaceutics